Totally Implantable Venous Access Device in Children with Cancer Lead to Disfiguring scar

REFERENCES

• Kinahan KE, Sharp LK, Seidel K, Scarring, disfigurement, and quality of life in long-term survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2012;30:2466–2474.
   PubMed Web of Science ®Google Scholar
• Van Dijk EM, van Dulmen-den Broeder E, Kaspers GJL, Psychosexual functioning of childhood cancer survivors. Psychooncology. 2008;17:506–511.
   PubMed Web of Science ®Google Scholar
• Kock HJ, Pietsch M, Krause U, Implantable vascular access systems: experience in 1500 patients with totally implantable central venous port systems. World J Surg. 1998;22:12–16.
   PubMed Web of Science ®Google Scholar
• Goltz JP, Noack C, Petritsch B, Totally implantable venous power ports of the forearm and the chest: initial clinical experience with port devices approved for high-pressure injections. Br J Radiol. 2012;85:e966–e972.
   Google Scholar
• Al-Abdullah T, Plint AC, Fergusson D. Absorbable versus nonabsorbable sutures in the management of traumatic lacerations and surgical wounds. Pediatr Emerg Care. 2007;23:339–344.
   PubMedGoogle Scholar
• D'Angelo F, Ramacciato G, Caramitti A, Totally implantable venous access systems, analysis of complications. Minerva Chir. 1997;52:937–942.
   PubMedGoogle Scholar
• Nam SO, Kim DY, Kim SC, Complications and risk factors of infections in pediatric hemato-oncology patients with totally implantable access ports (TIAPs). Pediatr Blood Cancer. 2010;54:546–551.
   PubMedGoogle Scholar
• Hengartner H, Berger C, Nadal D, Port-A-Cath infections in children with cancer. Eur J Cancer. 2004;40:2452–2458.
   PubMed Web of Science ®Google Scholar
• Sarper N, Zengin E, Corapçioglu F, Totally implantable central venous access devices in children with hemato-oncologic malignancies: evaluation of complications and comparison of incidence of febrile episodes with similar patients without central venous access devices. Pediatr Hematol Oncol. 2006;23:459–470.
   PubMed Web of Science ®Google Scholar
• Munro FD, Gillett PM, Wratten JC, Totally implantable central venous access devices for pediatric oncology patients. Med Pediatr Oncol. 1999;33:377–381.
   PubMedGoogle Scholar
• Lee DW, Kim YS, Park BY. Simultaneous correction of scars and tissue deficiency with composite grafts in secondary cleft lip deformity. J Oral Maxillofac Surg. 2012;70:e419–e427.
   Google Scholar
• Wolfram D, Tzankov A, Pülzi P, Hypertrophic scars and keloids –a review of their pathophysiology, risk factors and therapeutic management. Dermatol Surg. 2009;35:171–181.
   PubMed Web of Science ®Google Scholar
• Bang RL, Latif Al-Bader A, Sharma PN, Trace elements content in serum, normal skin, and scar tissues of keloid and normal scar patients. J Trace Elem Exp Med. 2002;15:57–66.
   Google Scholar
• Bayat A, Block O, Mrowietz U, Genetic susceptibility to keloid disease and hypertrophic scarring: transforming growth factor ß1 common polymorphisms and plasmas levels. Plast Reconstr Surg. 2003;111:535–543.
   PubMedGoogle Scholar
• Gangemi EN, Gregori D, Berchialla P, Epidemiology and risk factors for pathologic scarring after burn wounds. Arch Facial Plast Surg. 2008;10:93–102.
   PubMed Web of Science ®Google Scholar
• Child FJ, Fuller LC, Higgins EM, A study of the spectrum of skin disease occurring in a black population in south-east London. Br J Dermatol. 1999;141:512–517.
   PubMedGoogle Scholar
• Shaffer JJ, Taylor SC, Cook-Bolden F. Keloidal scars: a review with a critical look at therapeutic options. J Am Acad Dermatol. 2002;46(2):S63–S97.
   Google Scholar
• Fitzpatrick TB. The validity and practicality of sun-reactive skin type I-VI. Arch Dermatol. 1988;124:869–871.
   PubMed Web of Science ®Google Scholar
• Gottlöber P, Steinert M, Bähren W, Interferon-gamma in 5 patients with cutaneous radiation syndrome after radiation therapy. Int J Radiation Oncology Biol Phys. 2001;50:159–166.
   PubMed Web of Science ®Google Scholar
• Schäcke H, Döcke WD, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther. 2009;96:23–43.
   Google Scholar
• Capewell S. Reynolds S, Shuttleworth D, Purpura and dermal thinning associated with high dose inhaled corticosteroids. Br Med J. 1990;300:1548–1551.
   PubMed Web of Science ®Google Scholar
• Baryza MJ, Baryza GA. The Vancouver Scar Scale: an administration tool and its interrater reliability. J Burn Care Rehabil. 1995;16:535–538.
   PubMedGoogle Scholar
• Forbes-Duchart L, Marshall S, Strock A, Determination of inter-rater reliability in pediatric burn scar assessment using a modified version of the Vancouver Scar Scale. J Burn Care Res. 2007;28:460–467.
   PubMedGoogle Scholar
• Nedelec B, Correa JA, Rachelska G, Quantitive measurements of hypertrophic scar: Intrarater reliability, sensitivity, and specificity. J Burn Care Res. 2008;29:489–450.
   PubMed Web of Science ®Google Scholar
• Balfour-Lynn IM, Malbon K, Burman JF, Thrombophilia in children with cystic fibrosis. Pedatr Pulmonol. 2005;39:306–310.
   PubMedGoogle Scholar
• Sola JE, Stone MM, Wise B, Atypical thrombotic and septic complications of totally implantable venous access devices in patients with cystic fibrosis. Pediatr Pulmonol. 1992;14:239–242.
   PubMedGoogle Scholar
• Bartram JL, O'Driscoll S, Kulasekararaj AG, Portacaths are safe for long-term regular blood transfusion in children with sickle cell anaemia. Arch Dis Child. 2011;96:1082–1084.
   PubMedGoogle Scholar
• Van der Kar AL, Corion LUM, Smeulders MJC, Reliable and feasible evaluation of linear scars by patient and observe scar assessment scale. Plast Reconstr Surg. 2005;116:514–522.
   PubMedGoogle Scholar
• Gold MH, Foster TD, Adair MA, Prevention of hypertrophic scars and keloids by the prophylactic use of topical silicone gel sheets following a surgical procedure in an office setting. Dermatol Surg. 2001;27:641–644.
   PubMed Web of Science ®Google Scholar
• Atiyeh BS. Nonsurgical management of hypertrophic scars: evidence-based therapies, standard practices, and emerging methods. Aesth Plast Surg. 2007;31(5):468–492.
   PubMedGoogle Scholar